BioStem Technologies, Inc. (BSEM)
5.50
-0.78
(-12.42%)
USD |
OTCM |
Feb 11, 15:59
BioStem Technologies Market Cap : 92.21M for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 37.15M |
| Iovance Biotherapeutics, Inc. | 1.030B |
| Protokinetix, Inc. | 3.250M |
| GB Sciences, Inc. | 0.1628M |
| Travere Therapeutics, Inc. | 2.706B |
Market Cap Related Metrics
| PE Ratio | 6.461 |
| PS Ratio | 0.5202 |
| PEG Ratio | 0.1611 |
| Price to Book Value | 1.844 |
| Price to Free Cash Flow | 10.01 |
| Price | 5.50 |
| Earnings Yield | 15.48% |
| PEGY Ratio | 0.1611 |
| Operating PE Ratio | 8.000 |
| Normalized PE Ratio | 6.461 |